JP Patent

JP7148533B2 — セピプテリン及びその塩の多形

Assigned to PTC Therapeutics MP Inc · Expires 2022-10-05 · 4y expired

What this patent protects

Patent listed against Sephience.

Drugs covered by this patent

Sephience (SEPIAPTERIN) · Ptc Therap

Patent Metadata

Patent number: JP7148533B2
Jurisdiction: JP
Classification: —
Expires: 2022-10-05
Drug substance claim: No
Drug product claim: No
Assignee: PTC Therapeutics MP Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.